Evidence map›Paper›PMID 37231163›Full record

ArticleNature cell biology2023

Divergent metabolic programmes control two populations of MAIT cells that protect the lung.

Thomas Riffelmacher, Mallory Paynich Murray, Chantal Wientjens, Shilpi Chandra, Viankail Cedillo-Castelán, Ting-Fang Chou, Sara McArdle, Christopher Dillingham, Jordan Devereaux, Aaron Nilsen and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Nature cell biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Metabolic control of innate-like T cells.Nature reviews. Immunology · 2026
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Innateness transcriptome gradients characterize mouse T lymphocyte populations.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Article
  16. Review
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Thomas Riffelmacher *La Jolla Institute for Immunology, La Jolla, CA, USA. triffelmacher@lji.org.ORCID http://orcid.org/0000-0002-0372-5272
Mallory Paynich Murray *La Jolla Institute for Immunology, La Jolla, CA, USA.
Chantal WientjensLa Jolla Institute for Immunology, La Jolla, CA, USA.
Shilpi ChandraLa Jolla Institute for Immunology, La Jolla, CA, USA.
Viankail Cedillo-CastelánLa Jolla Institute for Immunology, La Jolla, CA, USA.
Ting-Fang ChouLa Jolla Institute for Immunology, La Jolla, CA, USA.
Sara McArdleLa Jolla Institute for Immunology, La Jolla, CA, USA.
Christopher DillinghamLa Jolla Institute for Immunology, La Jolla, CA, USA.
Jordan DevereauxOregon Health and Science University, Portland, OR, USA.
Aaron NilsenOregon Health and Science University, Portland, OR, USA.
Simon BrunelLa Jolla Institute for Immunology, La Jolla, CA, USA.
David M LewinsohnOregon Health and Science University, Portland, OR, USA.
Jeff HastyDepartment of Molecular Biology, University of California San Diego, La Jolla, CA, USA.
Gregory SeumoisLa Jolla Institute for Immunology, La Jolla, CA, USA.
Christopher A BenedictLa Jolla Institute for Immunology, La Jolla, CA, USA.
Pandurangan VijayanandLa Jolla Institute for Immunology, La Jolla, CA, USA.
Mitchell KronenbergLa Jolla Institute for Immunology, La Jolla, CA, USA. mitch@lji.org.ORCID http://orcid.org/0000-0001-6318-6445
La Jolla Institute for Immunology · USOregon Health & Science University · USUniversity of California San Diego · US

Funding

The role of TRAIL in immune control of cytomegalovirusR01AI101423 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI BENEDICT, CHRISTOPHER A · 2013 to 2023
$4.6M
CD4 T cell control of cytomegalovirusR01AI139749 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI BENEDICT, CHRISTOPHER A · 2019 to 2023
$3.2M
Training in Immunological MechanismsT32AI125179 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2016 to 2025
$3.1M
NovaSeq5000 High Throughput SequencerS10OD025052 · OD · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SEUMOIS, GREGORY · 2018 to 2018
$832k
Illumina HiSeq 2500 Sequencing SystemS10OD016262 · OD · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI RAO, ANJANA · 2013 to 2013
$600k
Super-resolution confocal microscopeS10OD021831 · OD · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI LEY, KLAUS F. · 2017 to 2017
$566k
FACSAria II Cell SorterS10RR027366 · NCRR · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2011 to 2011
$514k
NCRR NIH HHS S10 RR027366NIAID NIH HHS R01 AI101423NIAID NIH HHS R01 AI139749NIAID NIH HHS T32 AI125179NIH HHS S10 OD016262NIH HHS S10 OD021831NIH HHS S10 OD025052Wellcome Trust 210842/Z/18/ZWellcome Trust 210842_Z_18_Z
6 · The paper itself

Abstract

Although mucosal-associated invariant T (MAIT) cells provide rapid, innate-like responses, they are not pre-set, and memory-like responses have been described for MAIT cells following infections. The importance of metabolism for controlling these responses, however, is unknown. Here, following pulmonary immunization with a Salmonella vaccine strain, mouse MAIT cells expanded as separate CD127

Indexed as

Mucosal-Associated Invariant T CellsAnimalsLungMice

Identifiers

PMID37231163
PMCPMC10264248
OpenAlexW4378211904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.